共 50 条
- [24] Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction [J]. BMC Cardiovascular Disorders, 22
- [27] Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction [J]. ESC HEART FAILURE, 2021, 8 (03): : 2058 - 2069
- [29] Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction [J]. Clinical Research in Cardiology, 2019, 108 : 1074 - 1082
- [30] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction [J]. ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215